Neurocrine Biosciences | DEBITO

Debt Cambiamento Data
Acadia Pharmaceuticals USD 0 0 2022-06
Agios Pharmaceuticals USD 1.14M 84K 2022-09
Exelixis USD 0 0 2022-03
Gilead Sciences USD 24.98B 264M 2023-09
Intra Cellular Therapies USD 0 0 2022-06
Prothena USD 0 0 2022-06
Ultragenyx Pharmaceutical USD 0 0 2022-06



Neurocrine Biosciences DEBITO - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - May 2024.